Simoes, AR, González, SC, Lopez-Doldan, MD, Duran, G, Fernández-Montes, A, Fernandez, MP, Fernandez, MS, Mata, JG, Paez, D, Riera, P, Guino, E, Lopez-Fernandez, L, de Santiago, BG, Aspiroz, EL, Rojas, A, Castells, A, Castellvi-Bel, S, Ponte, CR, Vymetalkova, V, Carracedo, A, Fernandez-Rozadilla, C. Novel approaches for the discovery of pharmacogenetic biomarkers of chemotoxicity in patients with colorectal cancer. BRITISH JOURNAL OF PHARMACOLOGY. 2025; 182(21)DOI:10.1111/bph.70051. PMID:40624839. IF:7.700(Q1/1D).

Isla, D, Zugazagoitia, J, Arriola, E, García-Campelo, R, Blanco, CM, Diz-Taín, MP, Lopez-Brea, M, Moreno-Vega, AL, León-Mateos, L, Oramás, J, Gutiérrez-Calderón, V, Majem, M, Sánchez-Hernández, A, Aguado, C, Alvarez-Cabellos, R, Massutí, B, Moreno, A, Fírvida-Pérez, JL, Valdivia, J, González-Cordero, M, Zafra-Poves, M, Dómine, M, Garcia-Navalon, FJ, Villanueva, N, Provencio, M, Juan-Vidal, O, Rivas-Corredor, C, García, MEO, Palmero, R, López-Castro, R, Carcereny, E, Lechuga, JL, Domínguez, M, Callejo, A, Paz-Ares, L. Durvalumab plus platinum-etoposide in the first-line treatment of extensive-stage small cell lung cancer (CANTABRICO): A single-arm clinical trial. LUNG CANCER. 2025; 209DOI:10.1016/j.lungcan.2025.108763. PMID:41033130. IF:4.400(Q1/2D).

Soler, G, Grávalos, C, Rivera, F, Safont, MJ, Virgili, AC, Valladares-Ayerbes, M, Ferreiro-Monteagudo, R, Ortiz-Morales, MJ, Polo-Marques, E, Kornusova-Bersheva, I, Soustre, E, Yao, WY, Élez, E. Predictive factors of efficacy for FTD/TPI plus bevacizumab in refractory metastatic colorectal cancer patients: a subanalysis of the Spanish cohort from the SUNLIGHT phase III trial. Clinical & Translational Oncology. 2025; 27(11)DOI:10.1007/s12094-025-03907-z. PMID:40338282. IF:2.500(Q3/6D).

Cortellini, A, Garbo, E, La Cava, G, Citarella, F, Santo, V, Brunetti, L, Pinato, DJ, Naidoo, J, Loza, M, Genova, C, Gettinger, S, Kim, SY, Jayakrishnan, R, El Zarif, T, Russano, M, Pecci, F, Di Federico, A, Montrone, M, Owen, DH, Signorelli, D, Li, MJ, Camerini, A, Halmos, B, Vincenzi, B, Metro, G, Yendamuri, S, Grossi, F, Josephides, E, Tomasik, B, Giusti, R, Bria, E, Sebastian, M, Rost, M, Acker, F, Landi, L, Mazzoni, F, Morabito, A, Leonetti, A, Cantini, L, Mountzios, G, Kalvapudi, S, O'Reilly, D, Karapanagiotou, E, Monnet, I, Baena, J, Macerelli, M, Majem, M, Piedra, A, Cortinovis, DL, Tonini, G, Minuti, G, Mezquita, L, Gorria, T, Beninato, T, Lo Russo, G, Prelaj, A, De Giglio, A, Biello, F, Nana, FA, Dingemans, AMC, Aerts, JG, Ferrara, R, Abu Hejleh, T, Takada, K, Naqash, AR, Garassino, MC, Wakelee, HA, Nassar, A, Ricciuti, B, Soda, P, Caruso, CM, Guarrasi, V. Long-term outcomes from pembrolizumab monotherapy in patients with advanced NSCLC, PD-L1 expression = 50 %, and poor performance status: Transformer-based AI to characterize prognostic complexity. LUNG CANCER. 2025; 209DOI:10.1016/j.lungcan.2025.108799. PMID:41108882. IF:4.400(Q1/2D).

Volta-Durán, E, Sánchez, JM, Favaro, MTP, Martinez-Cuentra, G, Contreras, E, di Somma, A, López-Laguna, H, Unzueta, U, Casanova, I, Mangues, R, Villaverde, A, Vázquez, E. Self-disintegrating protein-leaking microparticles for topical protein delivery. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES. 2025; 329DOI:10.1016/j.ijbiomac.2025.147730. PMID:40967544. IF:8.500(Q1/1D).

Carrasco-Díaz, LM, Otero-Mateo, M, Alamo, P, Gallardo, A, Virgili, AC, Páez, D, Voltà-Durán, E, Villaverde, A, Vázquez, E, Unzueta, U, Casanova, I, Alba-Castellon, L, Mangues, R. Nanotoxin induces in situ pyroptosis to sensitize aPD1 to ablate metastases in microsattellite stable colorectal cancer. PHARMACOLOGICAL RESEARCH. 2025; 221DOI:10.1016/j.phrs.2025.107982. PMID:41083088. IF:10.500(Q1/1D).

Sansa, A, Vásquez, R, Valero, C, Vázquez, C, Holgado, A, Gayà, J, Rubio, D, León, X. Prognostic value of pretreatment peripheral blood biomarkers in patients with head and neck squamous cell carcinoma treated with chemo/bioradiotherapy. Clinical & Translational Oncology. 2025; 27(11)DOI:10.1007/s12094-025-03897-y. PMID:40323571. IF:2.500(Q3/6D).

Vilaseca, VG, Perez, ES, Fabrego, IE, Peral, IL, Prat, AM. Wolf's isotopic phenomenon in a patient with T-cell lymphoblastic lymphoma. MEDICINA CLINICA. 2025; 165(5)DOI:10.1016/j.medcli.2025.107073. PMID:40543401. IF:2.100(Q2/3D).

Grasa, E, Forment, A, Alonso-Solís, A, Ramalho, L, Roldán, A, Pousa, E, Aussó, S, Berdun, J, Tesoro, AG, Escudero, J, Corripio, I. Defining the Patient Journey and Identifying Digital Health Solutions in Treatment-Resistant Schizophrenia. ACTAS ESPANOLAS DE PSIQUIATRIA. 2025; 53(6)DOI:10.62641/aep.v53i6.1959. PMID:41437755. IF:1.600(Q3/7D).

Serra-Lopez, J, Miranda, A, Soria, A, Lopez, N, Castañon, E, Majem, M. Clinical practice guide for nurses that optimizes nurse's comprehensive care of patients undergoing immunotherapy. Enfermeria Clinica. 2025; 35(6)DOI:10.1016/j.enfcle.2025.502193. PMID:40204238. IF:(Q/D).

Miró, O, Ivars, N, Espinosa, B, Jacob, J, Alquézar-Arbé, A, Gil, V, Bellido, A, Serrano, L, Herrero-Puente, P, Fortuny, MJ, Mir, M, Soy, E, Esquivias, MA, Tost, J, Travería, L, Domingo, E, Noceda, J, López-Diez, MP, Aguirre, A, Alonso, H, Romero, M, López-Grima, ML, López, ML, Mueller, C, Peacock, WF, Puente, PH. Use of nebulized bronchodilators in acute heart failure: impact on outcomes. Internal and Emergency Medicine. 2025; 20(8)DOI:10.1007/s11739-025-04123-x. PMID:41162690. IF:3.800(Q1/2D).

Gómez-Hidalgo, NR, Cabrera, S, Bebia, V, García-Pineda, V, Padilla-Iserte, P, Fabregas, FF, Fuste, P, Alonso, P, Rodriguez, TG, Fernandez-Gonzalez, S, Chacon, E, Alvarez, JAP, Oliver, R, Gil-Moreno, A. The MULTISENT Study: A Multicenter Study on the Detection Rate of Sentinel Lymph Node Mapping in Endometrial Cancer Across Spain. ANNALS OF SURGICAL ONCOLOGY. 2025; 32(12)DOI:10.1245/s10434-025-17836-2. PMID:40702200. IF:3.500(Q1/2D).

Martinez-Brocca, Maria Asuncion, Bellido, Virginia, Cardona-Hernandez, Roque, Castaño, Luis, Conget, Ignacio, Fernandez, Alberto, Gomez Gila, Ana Lucia, Leiva-Gea, Isabel, Mauricio, Didac. Executive summary. Screening, staging and follow-up of type 1 diabetes in preclinical stages: consensus of the scientific societies SED, SEEN and SEEP.. Anales De Pediatria. 2025; 103(5)DOI:10.1016/j.anpede.2025.503944. PMID:. IF:(Q/D).

Llao, J, Mañosa, M, Martín-Arranz, E, Zabana, Y, Navarro-Llavat, M, Téller, M, Garcia-Planella, E, Busquets, D, Monfort, D, Pineda, JR, Gutiérrez, A, Villoria, A, Menchén, L, Bastida, G, García-Alonso, FJ, Rivero, M, Chaparro, M, de Francisco, R, Merino, O, Rodríguez-Lago, I, Acosta, MBD, Rodríguez-Fortúnez, P, Rodríguez-Jiménez, C, Calafat, M, Domènech, E. Addition of pulse corticosteroids to oral prednisone in moderately active ulcerative colitis: a randomized, multicentre, open-label study by GETECCU. Journal of Crohns & Colitis. 2025; 19(11)DOI:10.1093/ecco-jcc/jjaf182. PMID:41258993. IF:8.700(Q1/1D).

Vega-Abellaneda, S, Román, E, Soler, Z, Ortiz, MA, Rossi, G, Biagini, L, Sánchez, E, Pons-Tarin, M, Laghi, L, Mengucci, C, Kaur, N, Poca, M, Cuyàs, B, Serrano-Gomez, G, Alvarado, E, Manichanh, C, Soriano, G. A Metagenomics Approach to Frailty in Patients With Cirrhosis Undergoing a Multifactorial Intervention. LIVER INTERNATIONAL. 2025; 45(12)DOI:10.1111/liv.70418. PMID:41174950. IF:5.200(Q1/2D).

Melmed, S, di Filippo, L, Fleseriu, M, Mercado, M, Karavitaki, N, Gurnell, M, Salvatori, R, Tsagarakis, S, Losa, M, Maffei, P, Pereira, AM, Geer, EB, Katznelson, L, van der Lely, AJ, Bollerslev, J, Esposito, D, Webb, SM, Zatelli, MC, Valassi, E, Neggers, S, Chanson, P, Ho, KKY, Ioachimescu, AG, Biller, BMK, Samson, SL, Kaiser, UB, Schilbach, K, Luque, RM, Casanueva, FF, Shimon, I, Boguszewski, CL, Biermasz, N, Colao, A, Pirchio, R, Lamberts, SWJ, Kadioglu, P, Buchfelder, M, Frara, S, Chiloiro, S, Petersenn, S, Gadelha, MR, Puig-Domingo, M, Luger, A, Brue, T, Beckers, A, Ferone, D, Clemmons, DR, Greenman, Y, Marazuela, M, Mortini, P, Strasburger, CJ, Giustina, A. Consensus on acromegaly therapeutic outcomes: an update. Nature Reviews Endocrinology. 2025; 21(11)DOI:10.1038/s41574-025-01148-2. PMID:40804505. IF:40.000(Q1/1D).

Portu, M, Martinez-Recio, S, Barba, A, Gonzalez, A, López, L, Catasús, L, Majem, M. First-Line Osimertinib in a Patient Having NSCLC With a Rare Duplication Mutation in the EGFR Exon 19 Region (NM_005228.5:c.2214_2231dup p.(Ile740_Lys745dup)). Clinical Lung Cancer. 2025; 26(7)DOI:10.1016/j.clic.2025.07.013. PMID:40774920. IF:3.300(Q2/4D).

Cardozo, AR, Tibau, A, Liu, I, Han, J, Cliff, E, Kesselheim, A. Assessing outcomes emerging after confirmatory trials of accelerated approval drugs, 1992-2021. ANNALS OF ONCOLOGY. 2025; 36DOI:10.1016/j.annonc.2025.08.2894. PMID:. IF:65.400(Q1/1D).

Cardozo, AR, Kesselheim, A, Tibau, A. Magnitude of clinical benefit demonstrated in trials supporting FDA and EMA Approval of drugs for hematological malignancies, 2020-2024. ANNALS OF ONCOLOGY. 2025; 36DOI:10.1016/j.annonc.2025.08.1886. PMID:. IF:65.400(Q1/1D).

Martin-Broto, J, Ospina, GM, Garcia, AS, Trufero, JM, Martinez-Garcia, J, Fidalgo, JAP, Morales, CMV, Jurado, JC, Ledesma, P, Grifman, M, Moura, DD, Muñiz, NH. CIRTUSARC: A multicenter, open-label phase II trial of cirtuvivint as second-line therapy in selected advanced soft-tissue sarcomas. ANNALS OF ONCOLOGY. 2025; 36DOI:10.1016/j.annonc.2025.08.3354. PMID:. IF:65.400(Q1/1D).

Casasayas, M, Holgado, A, León, X, Kolanczak, K, Pérez-Sempere, M, Quer, M, Gras-Cabrerizo, JR. Endoscopic-assisted maxillectomy: our experience in tumours affecting the posterior wall of the maxillary sinus. JOURNAL OF LARYNGOLOGY AND OTOLOGY. 2025; 139(11)DOI:10.1017/S0022215125102958. PMID:40734309. IF:0.800(Q3/8D).

Benitez-Amaro, A, Garcia, E, Lhoëst, MTL, Martínez, A, Borrás, C, Tondo, M, Céspedes, MV, Caruana, P, Pepe, A, Bochicchio, B, Cenarro, A, Civeira, F, Prades, R, Escola-Gil, JC, Llorente-Cortés, V. Targeting LDL aggregation decreases atherosclerotic lipid burden in a humanized mouse model of familial hypercholesterolemia: Crucial role of ApoB100 conformational stabilization. ATHEROSCLEROSIS. 2025; 410DOI:10.1016/j.atherosclerosis.2024.118630. PMID:39547850. IF:5.700(Q1/1D).

Asenjo-Lobos, C, Arancibia, M, Garcia-Ribera, C, Cortés-Jofré, M, Huang, TM, Li, T, Madrid, E, Leucht, S. Comparative efficacy and safety of Clozapine vs. Quetiapine in schizophrenia and related disorders: An updated systematic review. PSYCHIATRY RESEARCH. 2025; 353DOI:10.1016/j.psychres.2025.116764. PMID:41101242. IF:3.900(Q1/2D).

Garcia-Patterson, A, Balsells, M, Solà, I, Corcoy, R. Detection and treatment of early gestational diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY. 2025; 233(5)DOI:10.1016/j.ajog.2025.04.059. PMID:40320104. IF:8.400(Q1/1D).

Sinsamala, RM, Anguita-Ruiz, A, Basagaña, X, Foraster, M, Gascon, M, Llurba, E, Luo, CL, Nieuwenhuijsen, MJ, Persavento, C, Rivas, I, Zhao, Y, Gomez-Roig, MD, Sunyer, J, Marcon, A, Johannessen, A, Dadvand, P. Holistic evaluation of the impact of pregnancy urban exposome on infant wheezing and chest infections: an outcome-wide approach. ENVIRONMENT INTERNATIONAL. 2025; 205DOI:10.1016/j.envint.2025.109900. PMID:41223798. IF:9.700(Q1/1D).

Mansilla-Polo, M, García-Moronta, C, Fernández-Crehuet, P, Garbayo-Salmons, P, Pons-Benavent, M, Aguilar-González, L, Jiménez-Gallo, D, Alcalá-García, R, Martín-Ezquerra, G, Martorell, A, Mahiques-Santos, L, Alfageme-Roldán, F, Escutia-Muñoz, B, Sahuquillo-Torralba, A, Fayos-Gregori, R, Soto-Moreno, A, Sánchez-Gutiérrez, I, Botella-Estrada, R, Vilarrasa, E, Molina-Leyva, A. Long-Term Effectiveness and Safety of Bimekizumab in Patients with Moderate to Severe Hidradenitis Suppurativa Under Real Clinical Practice Conditions: The Importance of Combined Treatment in Hurley III Patients and Potential Factors Associated with Complete Response. Dermatology and Therapy. 2025; 15(11)DOI:10.1007/s13555-025-01521-z. PMID:40866757. IF:4.200(Q1/1D).

Garin, N, Zarate-Tamames, B, Lertxundi, U, da Silva, IM, Orive, G, Crespo-Lessmann, A, de la Rosa, D. The environmental impact of inhalers: a framework for sustainable prescription practices in Spain. EUROPEAN JOURNAL OF HOSPITAL PHARMACY. 2025; 32(6)DOI:10.1136/ejhpharm-2024-004402. PMID:39788701. IF:1.500(Q4/8D).

Farré, A, Huguet, J, Basile, G, Diéguez, L, Izquierdo, P, Sánchez, R, Gavrilov, P, Gallioli, A, Faba, OR, Gaya, JM, Palou, J, Breda, A. Oncological outcomes for patients with European Association of Urology definitions of BCG failure treated with radical cystectomy. Actas Urologicas Espanolas. 2025; 49(9)DOI:10.1016/j.acuro.2025.501834. PMID:. IF:1.200(Q3/7D).

Downes, MR, Lajkosz, K, Algaba, F, Allory, Y, Amin, MB, Cheng, L, Desai, S, Eckstein, M, Hartmann, A, Lopez-Beltran, A, Mannweiler, S, van Montfoort, ML, Oxley, J, Paner, GP, Samaratunga, H, Shen, S, Warrick, J, Williamson, SR, Wobker, SE, van der Kwast, TH. Interobserver reproducibility of a hybrid three-tier grading system of papillary nonmuscle invasive urothelial carcinoma: an international Uropathology study. HISTOPATHOLOGY. 2025; 87(5)DOI:10.1111/his.15438. PMID:40058790. IF:4.100(Q1/1D).

Baboudjian, M, Leni, R, Oderda, M, Peyrottes, A, Kesch, C, Al-Nader, M, Uleri, A, Dariane, C, Baud, H, Olivier, J, Rios, AR, Sanguedolce, F, Benard, V, Windisch, O, Valerio, M, Gandaglia, G, Ploussard, G. Active Surveillance of Grade Group 2 Prostate Cancer: Oncological Outcomes from a Contemporary European Cohort. European Urology Oncology. 2025; 8(5)DOI:10.1016/j.euo.2025.01.009. PMID:39965999. IF:9.300(Q1/1D).

Oscullo, G, Méndez, R, Olveira, C, Giron, R, Garcia-Clemente, M, Máiz, L, Sibila, O, Golpe, R, Rodríguez-Hermosa, JL, Barreiro, E, Prados, C, Rodríguez-Lopez, J, de la Rosa, D, Martinez-Garcia, MA. What is the optimal dose of N-acetylcysteine in adult patients with bronchiectasis?-data from the RIBRON registry. Journal of Thoracic Disease. 2025; 17(10)DOI:10.21037/jtd-2025-1159. PMID:41229849. IF:1.900(Q3/7D).

Sandberg, M, Russell, G, Krol, P, Hayes, M, Bissette, R, Ben David, R, Patel, K, Aljabi, B, Byun, SS, Faba, OR, Marchinena, PG, Mourao, T, Ciancio, G, Peyton, CC, Zanotti, R, Spiess, PE, Mehrazin, R, Rais-Bahrami, S, Abreu, D, Zequi, SD, Rodriguez, AR. Comparing Cytoreductive Nephrectomy with Tumor Thrombectomy Between Open, Laparoscopic, and Robotic Approaches. Cancers. 2025; 17(21)DOI:10.3390/cancers17213490. PMID:41228283. IF:4.400(Q2/3D).

Van Gils, V, Jansen, WJ, van der Flier, WM, Martinez-Lage, P, Hort, J, Ramakers, IHGB, Rouaud, O, Laakso, M, Engelborghs, S, Popp, J, Lleó, A, Wallin, A, Tsolaki, M, Teunissen, CE, Vandenberghe, R, Freund-Levi, Y, Frölich, L, Zetterberg, H, Streffer, J, Lovestone, S, Moonen, J, Van Harten, A, Veverová, K, Legdeur, N, Den Braber, A, Damian, D, Hall, A, Bralten, J, Fanelli, G, Franke, B, Poelmans, G, Bulló, M, Jimenez-Murcia, S, Fernandez-Aranda, F, Salas-Salvadó, J, Dalsgaard, S, Visser, PJ, Vos, SJB. The association of diabetes with Alzheimer's disease biomarkers and vascular burden across European aging and memory clinic cohorts. ALZHEIMERS & DEMENTIA. 2025; 21(10)DOI:10.1002/alz.70804. PMID:41165072. IF:11.100(Q1/1D).

Mateu-Arrom, L, Nogueira, XAV, Puig, L, Spertino, J. Predictors of response to omalizumab and relapse in chronic spontaneous Urticaria: a narrative review focusing on parameters available in routine clinical practice. Frontiers In Allergy. 2025; 6DOI:10.3389/falgy.2025.1688464. PMID:41246132. IF:(Q/D).

Moreno, R, Rhodes, A, Ranzani, O, Salluh, JIF, Berger-Estilita, J, Coopersmith, CM, Juffermans, NP, Laffey, J, Reinikainen, M, Neto, AS, Tavares, M, Timsit, JF, Lopez, MDA, Arulkumaran, N, Azoulay, E, Chaudhuri, D, De Lange, D, De Waele, J, Dos Santos, CC, Du, B, Einav, S, Ferrer, R, Fujii, T, Gershengorn, HB, Haniffa, R, Hasan, MS, Hollenberg, S, Ippolito, M, Jung, CS, Kirov, M, Lakbar, I, Lipman, J, Liu, VC, Lobo, SM, Martin, GS, Metnitz, P, Myatra, SN, Oczkowski, S, Paiva, JA, Paruk, F, Pekkarinen, PT, Pilcher, D, Piquilloud, L, Pölkki, A, Prescott, HC, Blaser, AR, Rezende, E, Robba, C, Rochwerg, B, Schenck, EJ, Sendagire, C, Siaw-Frimpong, M, Simpkin, AJ, Soares, M, Summers, C, Szczeklik, W, Takala, J, Vincent, JL, Wendon, J, Zampieri, FG, Shankar-Hari, M, Singer, M. Rationale and Methodological Approach Underlying the Development of the Sequential Organ Failure Assessment (SOFA)-2 Score. JAMA Network Open. 2025; 8(10)DOI:10.1001/jamanetworkopen.2025.45040. PMID:41159829. IF:9.700(Q1/1D).

Tarantini, G, Fovino, LN, Covarrubias, HA, Wolny, R, Fabris, T, Nawara-Skipirzepa, J, Eden, M, Gomez, JLZ, Joner, M, Cuisset, T, Delgado, V, Rodés-Cabau, J, Saia, F, Bieliauskas, G, Van Belle, E, Modine, T, Rheude, T, Garot, P, Jung, CS, Rudolph, T, Leroux, L, Rottbauer, W, Nestelberger, T, Lhermusier, T, Nejjari, M, Regueiro, A, Meier, D, Fraccaro, C, Hartikainen, TS, Karam, N, Swaans, M, Rodrigues, JA, Dreger, H, Hengstenberg, C, Choudhury, D, Mauler-Wittwer, S, Piazza, N, Combaret, N, Letocart, V, Auffret, V, Durand, E, Urena, M, Del Valle, R, Drago, A, De Carlo, M, Diaz, VAJ, Dabrowski, M, Mascherbauer, J, Sudre, A, Ong, P, Gonska, B, Mancone, M, Fabris, E, Teles, R, Nombela-Franco, L, Asmarats, L, Vilalta, V, Protasiewicz, M, Webb, J, Toth, G, Zierer, A, Rioufol, G, Seiffert, M, Adamo, M, Meucci, F, Ielasi, A, Burzotta, F, Lopez, M, Loewenstein, I, Kralisz, P, Legutko, J, Huczek, Z, Pavei, A, Rakova, R, Wesselink, W, Zielinski, M, Greinert, D, Trushina, N, Zimmermann, L, Bramlage, P, Parma, R. ReTAVI Registry: Early Outcomes of Redo-TAVI with SAPIEN Platform in a Real-World Prospective Cohort. JACC-JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2025; 86(17)DOI:. PMID:. IF:22.300(Q1/1D).

Laudani, C, Ortega-Paz, L, Sionis, A, Calés, PV, Arevalos, V, Riba, RA, Morr, C, De Diego, O, Ortega, E, Dantas, AP, Angiolillo, D, Sabate, M, Ortiz-Pérez, JT, Brugaletta, S. Effect of DAPAgliflozin on Myocardial Fibrosis and Ventricular Function in Patients with ST-Segment Elevation Myocardial Infarction: the DAPA-STEMI Trial. JACC-JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2025; 86(17)DOI:. PMID:. IF:22.300(Q1/1D).

Zarbock, A, Strauss, C, Laflamme, M, Myjavec, A, Böhm, J, Burkert, J, Mazer, CD, de Varennes, B, Ginel Iglesias, A, Matschke, K, Larsson, TE, Reusch, M. POINTER: study protocol for a phase 2b, randomised, placebo-controlled, double-blind, parallel group dose-finding clinical study to evaluate the efficacy of RMC-035 on renal function and safety, in participants at high risk for kidney injury, following open-chest cardiac surgery. Trials. 2025; 26(1)DOI:10.1186/s13063-025-09124-x. PMID:41152991. IF:2.000(Q3/7D).

Araujo-Castro, M, García-Centeno, R, González, L, Nobre, EL, Severino, MD, Goi, J, Pena, MMP, Torre, EM, Aida, CL, Novoa-Testa, I, Cordido, F, Sánchón, R, Guerrero-Pérez, F, Rodríguez, RO, Rodríguez-Jiménez, B, García, MDO, Echarri, AI, Simó-Servat, A, Rodríguez, MDM, Novo-Rodríguez, C, Calatayud, M, Villar-Taibo, R, Bernabéu, I, Tenorio-Jimenéz, C, Molero, IG, Iglesias, P, Blanco, C, De Lara, FVO, Aulinas, A, Roca, QA, Fano, MP, Martínez, AR, Cardoso, LM, Marques, P, Giustina, A, Marazuela, M, Puig-Domingo, M, Biagetti, B. Prevalence and evolution of hypertension in a large Iberian cohort of patients with acromegaly. Pituitary. 2025; 28(6)DOI:10.1007/s11102-025-01586-1. PMID:41139153. IF:3.400(Q2/4D).

Araujo-Castro, M, García-Centeno, R, González, L, Hanzu, FA, Orois, A, Camara, R, García, MDO, Echarri, AI, Gimeno, PG, Pascual-Corrales, E, Biagetti, B, Cardona, A, Molero, IG, Simo-Servat, A, Pérez, FG, Villar-Taibo, R, Bernabéu, I, Fajardo-Montañana, C, Novo-Rodríguez, C, Jimenéz, CT, Calatayud, M, Rodríguez, MDM, Cordido, F, Castro, A, Valero, LM, Fano, MP, Goi, J, Aulinas, A, Abellán, P, Iglesias, P, Soto-Moreno, A. Real-World Data on the Efficacy and Safety of Osilodrostat in Patients with Cushing's Disease in Spain. Journal of Clinical Medicine. 2025; 14(21)DOI:10.3390/jcm14217575. PMID:41226972. IF:2.900(Q1/2D).